Correlation Between Puma Biotechnology and Virpax Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Puma Biotechnology and Virpax Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Puma Biotechnology and Virpax Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Puma Biotechnology and Virpax Pharmaceuticals, you can compare the effects of market volatilities on Puma Biotechnology and Virpax Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Puma Biotechnology with a short position of Virpax Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Puma Biotechnology and Virpax Pharmaceuticals.
Diversification Opportunities for Puma Biotechnology and Virpax Pharmaceuticals
-0.51 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Puma and Virpax is -0.51. Overlapping area represents the amount of risk that can be diversified away by holding Puma Biotechnology and Virpax Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Virpax Pharmaceuticals and Puma Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Puma Biotechnology are associated (or correlated) with Virpax Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Virpax Pharmaceuticals has no effect on the direction of Puma Biotechnology i.e., Puma Biotechnology and Virpax Pharmaceuticals go up and down completely randomly.
Pair Corralation between Puma Biotechnology and Virpax Pharmaceuticals
Given the investment horizon of 90 days Puma Biotechnology is expected to generate 0.4 times more return on investment than Virpax Pharmaceuticals. However, Puma Biotechnology is 2.52 times less risky than Virpax Pharmaceuticals. It trades about 0.0 of its potential returns per unit of risk. Virpax Pharmaceuticals is currently generating about -0.02 per unit of risk. If you would invest 389.00 in Puma Biotechnology on September 14, 2024 and sell it today you would lose (101.00) from holding Puma Biotechnology or give up 25.96% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Puma Biotechnology vs. Virpax Pharmaceuticals
Performance |
| Timeline |
| Puma Biotechnology |
| Virpax Pharmaceuticals |
Puma Biotechnology and Virpax Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Puma Biotechnology and Virpax Pharmaceuticals
The main advantage of trading using opposite Puma Biotechnology and Virpax Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Puma Biotechnology position performs unexpectedly, Virpax Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Virpax Pharmaceuticals will offset losses from the drop in Virpax Pharmaceuticals' long position.| Puma Biotechnology vs. Ultragenyx | Puma Biotechnology vs. Crinetics Pharmaceuticals | Puma Biotechnology vs. Arvinas | Puma Biotechnology vs. Revolution Medicines |
| Virpax Pharmaceuticals vs. Puma Biotechnology | Virpax Pharmaceuticals vs. Iovance Biotherapeutics | Virpax Pharmaceuticals vs. Day One Biopharmaceuticals | Virpax Pharmaceuticals vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Stocks Directory Find actively traded stocks across global markets |